Literature DB >> 29097624

DnaJ Homolog Subfamily B Member 9 Is a Putative Autoantigen in Fibrillary GN.

Nicole K Andeen1, Han-Yin Yang2, Dao-Fu Dai1, Michael J MacCoss2, Kelly D Smith3.   

Abstract

Fibrillary GN is a rare form of GN of uncertain pathogenesis that is characterized by the glomerular accumulation of randomly arranged, nonbranching fibrils (12-24 nm) composed of Ig and complement proteins. In this study, we used mass spectrometry to comprehensively define the glomerular proteome in fibrillary GN compared with that in controls and nonfibrillary GN renal diseases. We isolated glomeruli from formalin-fixed and paraffin-embedded biopsy specimens using laser capture microdissection and analyzed them with liquid chromatography and data-dependent tandem mass spectrometry. These studies identified DnaJ homolog subfamily B member 9 (DNAJB9) as a highly sampled protein detected only in fibrillary GN cases. The glomerular proteome of fibrillary GN cases also contained IgG1 as the dominant Ig and proteins of the classic complement pathway. In fibrillary GN specimens only, immunofluorescence and immunohistochemistry with an anti-DNAJB9 antibody showed strong and specific staining of the glomerular tufts in a distribution that mimicked that of the immune deposits. Our results identify DNAJB9 as a putative autoantigen in fibrillary GN and suggest IgG1 and classic complement effector pathways as likely mediators of the destructive glomerular injury in this disease.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  Fibrillary glomerulonephritis; autoantigen; immunohistochemistry; mass spectrometry; renal biopsy

Mesh:

Substances:

Year:  2017        PMID: 29097624      PMCID: PMC5748922          DOI: 10.1681/ASN.2017050566

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  32 in total

Review 1.  IgG Subclass Staining in Routine Renal Biopsy Material.

Authors:  Jessica Hemminger; Gyongyi Nadasdy; Anjali Satoskar; Sergey V Brodsky; Tibor Nadasdy
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

2.  Endoplasmic reticulum-resident chaperones modulate the inflammatory and angiogenic responses of endothelial cells.

Authors:  R Tsaryk; N M Bartholomä; N Simiantonaki; L Anspach; K Peters; C Heilmann; C J Kirkpatrick; F Pröls
Journal:  Br J Dermatol       Date:  2015-06-12       Impact factor: 9.302

3.  Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses.

Authors:  Surendra Dasari; Jason D Theis; Julie A Vrana; Roman M Zenka; Michael T Zimmermann; Jean-Pierre A Kocher; W Edward Highsmith; Paul J Kurtin; Ahmet Dogan
Journal:  J Proteome Res       Date:  2014-04-03       Impact factor: 4.466

4.  Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy.

Authors:  Sanjeev Sethi; Jason D Theis; Julie A Vrana; Fernando C Fervenza; Anjali Sethi; Qi Qian; Patrick Quint; Nelson Leung; Ahmet Dogan; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

5.  Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features.

Authors:  C E Alpers; H G Rennke; J Hopper; C G Biava
Journal:  Kidney Int       Date:  1987-03       Impact factor: 10.612

6.  Ultrastructural immunohistochemical localization of polyclonal IgG, C3, and amyloid P component on the congo red-negative amyloid-like fibrils of fibrillary glomerulopathy.

Authors:  G C Yang; R Nieto; I Stachura; G R Gallo
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

7.  Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

Authors:  Jordan L Rosenstock; Glen S Markowitz; Anthony M Valeri; Giuseppe Sacchi; Gerald B Appel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

8.  Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.

Authors:  Vincent Javaugue; Alexandre Karras; François Glowacki; Brigitte McGregor; Corinne Lacombe; Jean-Michel Goujon; Stéphanie Ragot; Pierre Aucouturier; Guy Touchard; Frank Bridoux
Journal:  Am J Kidney Dis       Date:  2013-06-04       Impact factor: 8.860

9.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Charles E Alpers; Jolanta Kowalewska
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

10.  A Multiplexed Single-Cell CRISPR Screening Platform Enables Systematic Dissection of the Unfolded Protein Response.

Authors:  Britt Adamson; Thomas M Norman; Marco Jost; Min Y Cho; James K Nuñez; Yuwen Chen; Jacqueline E Villalta; Luke A Gilbert; Max A Horlbeck; Marco Y Hein; Ryan A Pak; Andrew N Gray; Carol A Gross; Atray Dixit; Oren Parnas; Aviv Regev; Jonathan S Weissman
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

View more
  27 in total

1.  Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.

Authors:  Shaoshan Liang; Dacheng Chen; Dandan Liang; Feng Xu; Mingchao Zhang; Fan Yang; Xiaodong Zhu; Ping Li; Caihong Zeng
Journal:  J Nephrol       Date:  2020-06-18       Impact factor: 3.902

Review 2.  The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.

Authors:  Sanjeev Sethi; S Vincent Rajkumar; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2018-04-27       Impact factor: 10.121

Review 3.  The tissue proteome in the multi-omic landscape of kidney disease.

Authors:  Markus M Rinschen; Julio Saez-Rodriguez
Journal:  Nat Rev Nephrol       Date:  2020-10-07       Impact factor: 28.314

4.  Glomerular Disease Pathology in the Era of Proteomics: From Pattern to Pathogenesis.

Authors:  Mark Haas
Journal:  J Am Soc Nephrol       Date:  2017-11-02       Impact factor: 10.121

5.  Protein Mass Spectrometry Made Simple.

Authors:  Jon B Klein; Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2018-05-03       Impact factor: 10.121

6.  Fibrillary Glomerulonephritis: Clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort.

Authors:  Nicole K Andeen; Megan L Troxell; Maziar Riazy; Rupali S Avasare; Jessica Lapasia; J Ashley Jefferson; Shreeram Akilesh; Behzad Najafian; Roberto F Nicosia; Charles E Alpers; Kelly D Smith
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-04       Impact factor: 8.237

7.  Complete remission of DnaJ homolog subfamily B member 9-positive fibrillary glomerulonephritis following steroid monotherapy in an elderly Japanese woman.

Authors:  Takahiro Uchida; Shuuhei Komatsu; Takashi Sakai; Aki Kojima; Sachiko Iwama; Kentaro Sugisaki; Takashi Oda
Journal:  CEN Case Rep       Date:  2021-03-03

8.  Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis.

Authors:  Anne-Laure Faucon; Sophie Cereja; Charlotte Mussini; Jean-Michel Goujon; Valérie Caudwell
Journal:  J Nephrol       Date:  2022-02-24       Impact factor: 3.902

Review 9.  Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).

Authors:  Nattawat Klomjit; Mariam Priya Alexander; Ladan Zand
Journal:  Kidney360       Date:  2020-07-08

10.  Disentangling a Case of Glomerulonephritis with Fibrils.

Authors:  Pietro Canetta
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-02       Impact factor: 10.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.